U.S. Banks Stock News

NasdaqCM:MNSB
NasdaqCM:MNSBBanks

MainStreet Bancshares (MNSB) Net Interest Margin Resilience Tests Bullish Narratives In Q1 2026

MainStreet Bancshares (MNSB) has followed up its move back into profitability with Q1 2026 results that sit against a recent run of steady quarterly revenue and earnings, capped most recently by Q4 2025 revenue of about US$17.7 million and basic EPS of US$0.46 on net income of US$3.5 million. Over the last few quarters, the company has seen total revenue move from US$13.3 million in Q3 2024 to US$17.4 million in Q1 2025 and then to US$17.7 million in Q4 2025. Over the same period, quarterly...
NasdaqGS:COO
NasdaqGS:COOMedical Equipment

Is Cooper Companies (COO) Now Attractive After Recent Share Price Weakness?

If you are wondering whether Cooper Companies is starting to look better value after a weaker share price, this article walks through the key numbers that matter to you. The stock last closed at US$69.46, with returns of a 3.1% decline over 7 days, a 0.7% decline over 30 days, a 14.4% decline year to date, and an 11.7% decline over 1 year. These moves may have changed how some investors view its risk and opportunity profile. Recent coverage has focused on Cooper Companies within the broader...
NasdaqGM:ISTR
NasdaqGM:ISTRBanks

Investar Holding (ISTR) Rising Net Interest Margin Reinforces Bullish Profitability Narratives

Investar Holding (ISTR) has just put fresh numbers on the table for Q1 2026, with recent quarters showing total revenue stepping from US$20.2 million in Q4 2024 to US$23.2 million in Q4 2025 and quarterly EPS ranging between about US$0.46 and US$0.64 over 2025. Over the same period, trailing twelve month EPS moved from US$2.06 to US$2.22 while revenue on this basis went from US$83.2 million to US$93.3 million, giving investors a clear line of sight on how the top line and per share earnings...
NasdaqGS:CCBG
NasdaqGS:CCBGBanks

Capital City Bank Group (CCBG) Net Margin Near 25% Reinforces Bullish Earnings Narratives

Capital City Bank Group (CCBG) has just closed out Q4 2025 with total revenue of US$61.5 million and net income of US$13.7 million, translating into basic EPS of US$0.80 as the latest marker of its earnings run into Q1 2026. Over recent quarters the bank has seen revenue move from US$58.5 million in Q3 2024 to US$61.5 million in Q4 2025, while EPS has ranged between roughly US$0.77 and US$0.99, giving investors a clear view of how top line and per share profit have tracked together. Set...
NYSE:HLI
NYSE:HLICapital Markets

Houlihan Lokey Wins Special Committee Role In Complex BDC Review

Houlihan Lokey (NYSE:HLI) has been appointed financial advisor to the Special Committee of Investcorp Credit Management BDC, Inc. The mandate covers a review of potential alternatives for Investcorp Credit Management BDC, Inc.'s business. This assignment underscores the firm's role in complex corporate review processes. For investors tracking NYSE:HLI, this new advisory role comes with the stock at a share price of $160.99. The company shows a mixed recent pattern, with a 3.2% return over...
NYSE:DX
NYSE:DXMortgage REITs

Dynex Capital (DX) Net Margin Surge Tests Bearish Cash Flow Concerns

Dynex Capital (DX) has just reported new figures, with recent quarters showing total revenue moving from US$60.3 million in Q4 2024 to US$202.0 million in Q4 2025 and basic EPS shifting from US$0.61 to US$1.17 over the same period, alongside trailing 12 month net income of US$308.9 million. Over the past year, revenue has tracked from US$150.4 million on a trailing basis in Q4 2024 to US$372.1 million by Q4 2025, while trailing EPS has moved from US$1.50 to US$2.49. These figures provide a...
NasdaqGS:PCRX
NasdaqGS:PCRXPharmaceuticals

A Look At Pacira BioSciences (PCRX) Valuation After New EXPAREL Health Economic Data

Pacira BioSciences (PCRX) shares recently reacted to fresh health economic data on its flagship non opioid pain drug, EXPAREL, following presentations at the Academy of Managed Care Pharmacy Annual 2026 Meeting in Nashville. See our latest analysis for Pacira BioSciences. The new EXPAREL health economic data arrives alongside a 90 day share price return of 28.08% and a 30 day share price return of 11.80%. However, the 1 year total shareholder return of 4.56% and 5 year total shareholder...
NYSE:AEO
NYSE:AEOSpecialty Retail

3 Stocks Including Impinj That May Be Trading Below Their Estimated Value

The market in the United States has shown robust performance, climbing 4.0% in the last 7 days and achieving a 39% increase over the past year, with earnings projected to grow by 16% annually in the coming years. In such an environment, identifying stocks that are potentially undervalued can be key to maximizing investment opportunities, as these stocks may offer significant value relative to their current market price.
NYSE:MAX
NYSE:MAXInteractive Media and Services

April 2026's Top Growth Stocks With Strong Insider Ownership

The United States market has experienced a robust performance, climbing 4.0% in the last week and 39% over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, growth companies with strong insider ownership can be particularly appealing as they often indicate confidence from those closest to the business, aligning well with current market optimism.
NYSE:AIV
NYSE:AIVResidential REITs

Promising Penny Stocks To Watch In April 2026

The market has climbed 4.0% in the last 7 days and 39% over the past year, with earnings forecast to grow by 16% annually. Though often considered outdated, penny stocks still hold potential when supported by robust financials, offering opportunities that larger firms might overlook. We'll explore several penny stocks that stand out for their financial strength and potential for growth, appealing to investors looking for under-the-radar opportunities.
NYSE:AD
NYSE:ADWireless Telecom

Did Proposed Officer Liability Shield Just Shift Array Digital Infrastructure's (AD) Investment Narrative?

Array Digital Infrastructure, Inc. has proposed amending its Restated Certificate of Incorporation to add exculpation protections for certain corporate officers against monetary damages for breaches of the fiduciary duty of care, subject to limitations, with shareholders asked to vote on the change at the May 19, 2026 annual meeting. This move, which would extend protections similar to those already available to directors, raises important questions about how investors assess management...
NasdaqCM:ACIC
NasdaqCM:ACICInsurance

US Market's Undiscovered Gems 3 Promising Small Caps

The United States market has shown impressive momentum, climbing 4.0% in the past week and an astounding 39% over the last year, with earnings projected to grow by 16% annually in the coming years. In this thriving environment, identifying promising small-cap stocks that have yet to capture widespread attention can offer intriguing opportunities for investors seeking growth potential.
NYSE:FBK
NYSE:FBKBanks

How Stronger Net Interest Income and Buybacks Will Impact FB Financial (FBK) Investors

FB Financial Corporation recently reported its first-quarter 2026 results, with net interest income rising to US$145.97 million and net income to US$57.53 million, alongside higher earnings per share from continuing operations. The bank also disclosed modest net charge-offs of US$3.5 million and confirmed meaningful progress on its share repurchase program, retiring over 4.04% of its shares since the September 2025 authorization. We’ll now examine how this earnings strength, particularly...
NYSE:LH
NYSE:LHHealthcare

A Look At Labcorp (LH) Valuation As New Tests And AI Alzheimer’s Platform Gain Traction

Labcorp Holdings (LH) has been active on several fronts, launching an FDA cleared rapid fentanyl urine test, unveiling an AI based Alzheimer’s data platform, and expanding pediatric diagnostics through a new collaboration. See our latest analysis for Labcorp Holdings. At a share price of $270.68, Labcorp has a 1 day share price return of 1.62% and a year to date share price return of 7.56%, while its 1 year total shareholder return of 28.92% and 3 year total shareholder return of 40.58%...
NasdaqGS:RNW
NasdaqGS:RNWRenewable Energy

Does Vertically Integrated Solar Manufacturing Acceleration Change The Bull Case For ReNew Energy Global (RNW)?

In fiscal 2026, ReNew Energy Global commissioned about 2.4 GW of renewable assets, lifting its operating capacity to roughly 12.6 GW, while expanding its solar manufacturing footprint to 6.5 GW of module capacity and 2.5 GW of cell capacity across India. An interesting angle is the company’s vertically integrated model, where fast-growing in-house solar manufacturing, backed by a US$100 million British International Investments stake, underpins its expanding renewable power portfolio. We’ll...
NasdaqCM:SIDU
NasdaqCM:SIDUAerospace & Defense

Sidus Space (SIDU) Valuation Check As Lonestar Partnership Expands Orbital Data Storage Payload Work

Sidus Space (SIDU) is in focus after expanding its agreement with Lonestar Data Holdings and securing work on an additional StarVault orbital data storage payload, further strengthening its role in space-based sovereign data services. See our latest analysis for Sidus Space. At a share price of US$5.35, Sidus Space has seen a 131.60% 30 day share price return and a 23.56% year to date share price return, while the 1 year total shareholder return of 282.14% contrasts with a 3 year total...
NYSE:FHN
NYSE:FHNBanks

Should First Horizon’s Rising Net Interest Income and New Leadership Hires Require Action From FHN Investors?

First Horizon Corporation recently reported its first-quarter 2026 results, with net interest income rising to US$667 million and net income reaching US$263 million, while earnings per share from continuing operations increased versus the same period last year. Alongside the stronger earnings, First Horizon has been adding and promoting experienced private client and commercial banking leaders across key Gulf South markets, potentially reinforcing its wealth management and commercial banking...
NasdaqGM:FDBC
NasdaqGM:FDBCBanks

Undervalued Small Caps With Insider Buying Across Regions To Consider

Over the last 7 days, the United States market has risen by 4.0%, contributing to a remarkable 39% increase over the past year, with earnings projected to grow by 16% annually in the coming years. In this dynamic environment, identifying good stocks often involves looking for companies that are not only undervalued but also show signs of insider confidence, such as recent buying activity.
NYSE:DAO
NYSE:DAOConsumer Services

Insider Backed Growth Companies To Watch In April 2026

The United States market has shown robust performance, rising 4.0% in the past week and up 39% over the last year, with earnings projected to grow by 16% annually in the coming years. In such a thriving environment, growth companies with substantial insider ownership can be particularly appealing as they often reflect strong confidence from those closest to the business's core operations and strategy.
NYSE:SMRT
NYSE:SMRTElectronic

3 Promising Penny Stocks With Market Caps Up To $400M

Over the last 7 days, the United States market has risen by 4.0%, and over the past year, it has climbed 39%, with future earnings expected to grow annually by 16%. For those interested in smaller or newer companies, penny stocks — despite their somewhat outdated name — can offer surprising value when backed by solid financials. This article will explore three penny stocks that demonstrate financial strength and potential long-term promise for investors seeking opportunities in...
NasdaqGS:SOHU
NasdaqGS:SOHUEntertainment

US Market's Hidden Gems: 3 Promising Small Caps

Over the last 7 days, the United States market has risen by 4.0%, and over the past year, it has seen a robust increase of 39%, with earnings forecasted to grow by 16% annually. In this dynamic environment, identifying promising small-cap stocks can offer unique opportunities for investors seeking growth potential beyond the well-trodden paths of larger companies.